Cargando…
Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NASH
Hepatic iron overload (HIO) is a hallmark of nonalcoholic fatty liver disease (NAFLD) with a poor prognosis. Recently, the role of hepatic erythrophagocytosis in NAFLD is emerging as a cause of HIO. We undertook various assays using human NAFLD patient pathology samples and an in vivo nonalcoholic s...
Autores principales: | Park, Joon Beom, Ko, Kangeun, Baek, Yang Hyun, Kwon, Woo Young, Suh, Sunghwan, Han, Song-Hee, Kim, Yun Hak, Kim, Hye Young, Yoo, Young Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454295/ https://www.ncbi.nlm.nih.gov/pubmed/37629045 http://dx.doi.org/10.3390/ijms241612862 |
Ejemplares similares
-
Effect of erythrophagocytosis-induced ferroptosis during angiogenesis in atherosclerotic plaques
por: Puylaert, Pauline, et al.
Publicado: (2023) -
Ferroptosis of Endothelial Cells Triggered by Erythrophagocytosis Contributes to Thrombogenesis in Uremia
por: Li, Zhanni, et al.
Publicado: (2023) -
Effect of Cilostazol on the Neuropathies of Streptozotocin-Induced Diabetic Rats
por: Suh, Kwang Sik, et al.
Publicado: (1999) -
Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019) -
Effects of cilostazol against the progression of carotid IMT in symptomatic ischemic stroke patients
por: Heo, Sung Hyuk, et al.
Publicado: (2012)